What does Brexit mean for bioethics?
By Xavier Symons,
BioEdge
| 06. 25. 2016
It is tempting to provide an alarmist answer to this question. Yet it is wise to avoid the apocalyptic tone of recent media coverage and first to flag what is not going to change in UK biomedical ethics policy.
As highlighted by a post on the Christian Medical Fellowship Blogs, the UK will not (or, at least, not yet) be leaving the Council of Europe (CoE) – this entity does not fall under the auspices of the EU. That the UK will remain in the CoE is significant, as this is the umbrella organisation for what is known as the Committee on Bioethics, an influential policy body that seeks to apply principles outlined in the Convention on Human Rights and Medicine to new issues in medical technology and research.
The European Court on Human Rights also falls within the purview of the CoE. Importantly, The ECHR has handed down significant decisions within the area of conscientious objection in healthcare.
Yet some suggest the Brexit vote may effect disability rights legislation and regulations in the UK. EU directives about...
Related Articles
By Courtney Withers and Daryna Zadvirna, ABC News | 12.03.2025
Same-sex couples, single people, transgender and intersex West Australians will be able to access assisted reproductive technology (ART) and surrogacy, almost a decade after reforms were first promised.
The landmark legislation, which removes the requirement for people to demonstrate medical...
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
